Last updated: July 10, 2026

Application No. 19/462,985

Untitled Application

Unknown

Filed

Priority

Jun 02, 2020 — provisional 63/033,593 +2 more

Examiner

BUNNER, BRIDGET E

Art Unit

Tech Center

Ares Trading S.A.

Assignee

Ares Trading S.A.

OA Round

1 (Non-Final)

This examiner grants 64% of cases after interview

— +19.8% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 833 resolved cases, 2023–2026

Examiner Intelligence

BUNNER, BRIDGET E View full profile →

Grants 64% of resolved cases

Career Allowance Rate

535 granted / 833 resolved

+4.2% vs TC avg

Strong +20% interview lift

Without

With

+19.8%

Interview Lift

resolved cases with interview

Typical timeline

2y 10m

Avg Prosecution

34 currently pending

Career history

871

Total Applications

across all art units

Statute-Specific Performance

§101

1.9%

-38.1% vs TC avg

§103

23.0%

-17.0% vs TC avg

§102

21.5%

-18.5% vs TC avg

§112

23.8%

-16.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 833 resolved cases

Prosecution Timeline

Apr 01, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/429,093

Patent 12673985

A METHOD FOR THE TREATMENT OR PROPHYLAXIS OF CANCER BY TARGETING THE EXTRACELLULAR PORTION OF KERATIN 14 (KRT14) RESIDING ON CANCER CELLS

4y 11m to grant Granted Jul 07, 2026

16/470,719

Patent 12668628

SIRP-GAMMA TARGETED AGENTS FOR USE IN THE TREATMENT OF CANCER

7y 0m to grant Granted Jun 30, 2026

18/061,066

Patent 12661386

METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY

3y 6m to grant Granted Jun 23, 2026

18/121,468

Patent 12648966

Hematopoietic Stem Cell Engraftment

3y 2m to grant Granted Jun 09, 2026

17/255,108

Patent 12624085

COMPOSITIONS AND METHODS OF NKG2D CHIMERIC ANTIGEN RECEPTOR T CELLS FOR CONTROLLING TRIPLE-NEGATIVE BREAST CANCER

5y 4m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

64%

Grant Probability

84%

With Interview (+19.8%)

2y 10m

Median Time to Grant

Low

PTA Risk

Based on 833 resolved cases by this examiner. Grant probability derived from career allowance rate.